CompletedNot Applicable

Evaluation of Latent Pulmonary Arterial Hypertension in Congenital Shunt Lesions

Belgium93 participantsStarted 2015-01

Plain-language summary

Prospective, monocentric study for the evaluation of latent pulmonary arterial hypertension in patients with congenital shunt lesions lost to follow-up. Lost to follow-up is defined as latest clinical control ≥ 5 years.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Previous repair for secundum ASD, VSD Exclusion Criteria: * Other congenital heart disease * Chronic lung disease or total lung capacity \< 80% of predicted value * History of pulmonary embolism

What they're measuring

Mortality

Timeframe: From date of birth until date of study inclusion (up to 100 months)

Trial details

NCT IDNCT02552485

SponsorUniversitaire Ziekenhuizen KU Leuven

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2015-10

View on ClinicalTrials.gov More Atrial Septal Defects trials